IRCT2014041317246N1
Completed
未知
Evaluation of Typical Antipsychotic Augmentation with Sertraline in Reduction of Negative Symptoms in patients with Schizophrenia in Ahwaz Golestan Hospital
Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for this study are as follows: schizophrenia \- a negative score more than 15 in PANSS; no liver disease; not treated with ECT in the past six months; during illness for over one year; aged between 21 to 63 years old.
- •The Exclusion criteria are: depression; mental retardation; schizoaffective disorder; bipolar disorder; a neurological disorder such as epilepsy, Parkinson's disease; a risky physical illness such as cardiac ischemia or heart failure; use of antidepressants or lithium for whatever reason; Leisure drug; drug abuse within one recent month (except nicotine and caffeine); extrapyramidal side effects; deafness or dumbness active suicidal or homicidal thoughts; pregnant or lactating women; at least 3 months have passed since the last time the use of long\-acting antipsychotics; drugs with a history of hypersensitivity or serious interest in the study; the patient withdrew from the study and side effects.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
egative symptom treatment in schizophrenia disorderSchizophrenia disorder.paranoid schizophrenia, hebephrenic schizophrenia, catatonic schizophrenia ,undiffrentiated schizophreniaIRCT138902113843N1Ahvaz Jundishapur University of Medical Sciences40
Recruiting
Phase 2
Evaluation the effect of atypical antipsychotic augmentation with AtomoxetineSchizophrenia.SchizophreniaIRCT20100520003979N9Ahvaz University of Medical Sciences60
Recruiting
Not Applicable
The effects of antipsychotic maintenance therapy on brain volume: randomized (dis)continuation after remission of a first psychotic episode.Psychotic disorder / Schizophrenia10039628NL-OMON52454niversitair Medisch Centrum Groningen225
Completed
Not Applicable
Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins.psychosisschizophrenia10039628NL-OMON31735GGZ Groep Noord en Midden-Limburg100
Active, not recruiting
Not Applicable
Effectiveness of newer antipsychotic drugs compared to conventional antipsychotic drugs in patients with schizophreniaSchizophreniaMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2009-010966-47-DEniversität Bremen